AVI BioPharma And Gene Tools Expand License Agreement for Development of Diagnostic Products, Exchange $1 Million.
Business Wire › March 24, 2000
Linked as:
Extract
AVI BioPharma And Gene Tools Expand License Agreement for Development of Diagnostic Products, Exchange $1 Million.
Health/Medical Writers
PORTLAND, Ore.--(BW HealthWire)--March 24, 2000 AVI BioPharma (Nasdaq:AVII)(Nasdaq:AVIIW)(Nasdaq:AVIIZ) announced today that it rece...See the full content of this document
Sponsored links
